Dengue COVID-19 overlap: antigenic mimicry or concurrent two viral diseases
DOI:
https://doi.org/10.3329/bjms.v23i1.70712Keywords:
Dengue-COVID-19 overlap; COVID-19; antigenic mimicry; Post covid lung fibrosisAbstract
Background: Dengue-COVID-19 overlap is mixture of both diseases sharing few similarities in pulmonary and extrapulmonary involvement. Due to high prevalence of both diseases later being pandemic disease, and overlapping laboratory and clinical parameters we have conducted a study to observe dengue-COVID-19 overlap in Indian settings in tertiary care hospitals.
Methods: Prospective, observational study, included 600 COVID-19 cases with dengue NS1 or Dengue IgM positive, with lung involvement documented and categorized on HRCT thorax at entry point. All cases were subjected to dengue IgG antibody titers and dengue IgM/IgG antibody titer analysis after 12 weeks of discharge form hospital.
Results: Dengue- COVID-19 overlap was documented in 16.33% (98/600) cases. CT severity has documented significant correlation with Dengue-COVID-19 overlap cases. [p<0.00001] Hematological evaluation, white blood cell count & platelet count were having significant association with Dengue-COVID-19 overlap [p<0.0076] & [p<0.00001] respectively. Clinical parameters as hypoxia have significant association with dengue- COVID-19 overlap. [p<0.00001] Inflammatory markers as IL-6, CRP and LDH has significant association in dengue-COVID-19overlap [p<0.00001] respectively. In study of 98 cases of ‘Dengue-COVID-19’, post covid lung fibrosis [p<0.004] and serological assessment in dengue IgM/IgG and covid antibody titers has significant association [p<0.00001]
Conclusion: Dengue-COVID-19 overlap is clinical syndrome with overlapping clinical and laboratory workup of both the illnesses. High index of suspicion is must in all covid cases in tropical settings where dengue is endemic; and all cases with leucopenia and thrombocytopenia with fever should be screened for dengue serology. False positive dengue serology or dengue antigen crossreactivity is known to occur in underlying COVID-19 illness, and have impact on clinical outcome as it will result in delay in covid appropriate treatment initiation and many cases require intensive care unit treatment due to progressed covid pneumonia.
Bangladesh Journal of Medical Science Vol. 23 No. 01 January’24 Page : 189-199
Downloads
30
80
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Patil Shital, Sham Toshniwal, Uttareshvar Dhumal
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish in the Bangladesh Journal of Medical Science agree to the following terms that:
- Authors retain copyright and grant Bangladesh Journal of Medical Science the right of first publication of the work.
Articles in Bangladesh Journal of Medical Science are licensed under a Creative Commons Attribution 4.0 International License CC BY-4.0.This license permits use, distribution and reproduction in any medium, provided the original work is properly cited.- Authors are able to enter into separate, additional contractual arrangements for the distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted to post their work online (e.g., in institutional repositories or on their website) as it can lead to productive exchanges, as well as greater citation of published work.
